Back

Patient Perspectives on Buprenorphine Treatment for Opioid Use Disorder and Preferences for Long-Acting Injectable Formulations: Findings from a National Online Survey

2026-02-06 addiction medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundLong-acting injectable buprenorphine (LAIB) has been positioned as a potentially transformative option for opioid use disorder (OUD), in part because patient experiences reported in qualitative studies emphasize reduced daily burden, increased "freedom," reduced stigma, and fewer pressures related to diversion--while also noting barriers such as insufficient information, early adverse experiences, and concerns about coercion. MethodsWe conducted a cross-sectional online survey of adul...

Predicted journal destinations